Forgot Password?
Return to Course Listing

CME: Prevention and management of influenza infection

Activity Description / Statement of Need:

In this online, self-learning activity:

Influenza has been recognized as a global public health menace since at least 100 years ago with the 1918-19 pandemic, which infected an estimated one-third of the world’s population and was responsible for the deaths of one in ten, or 50 million, of those infected. While some have contended that a significant number of deaths associated with the 1918 pandemic may have actually been attributable to acid-base derangements and pulmonary edema associated with contemporary aspirin dosing in the toxic range of two to eight times what is presently the maximum recommended dose – it remains a significant public health concern, with the 2017-2018 flu season in recent decades with an estimated 80,000 deaths (typical range 12,000-56,000 per year),coming with an annual cost of $16 billion.

Podcast available at: Apple Podcasts or wherever you get your podcasts.

Target Audience:

Healthcare professionals specializing in: infectious disease, internal medicine, and pediatrics; physician assistants, nurse practitioners, nurses, and pharmacists who specialize in the aforementioned areas; and any other healthcare professionals with an interest in or who clinically encounter patients with influenza.

This program is supported by an educational grant from Sanofi Pasteur.

This activity is free of charge.

Release Date: July 23, 2019 -- Expiration Date: July 23, 2021

Faculty: Diane Birnbaumer, MD


Faculty introduction, disclosures

Epidemiology of and risk factors for acquiring influenza

  • Statistics – snapshots and trends
  • Transmission
  • Genotypes

 Pathogenesis and prevention of influenza

  • Onset
  • Risk factors, complications, and costs
  • Present vaccination recommendations and recent changes
  • Peds and adult vaccination recommendations
  • Benefits of maintaining yearly vaccination
  • Patient case(s)


  • Nonpharmacologic symptomatic management and supportive care
  • Historical vs. present pharmacotherapy
  • Impact on outcomes
  • Recently approved, novel treatments and their anticipated place in therapy
  • Patient case(s)

Barriers to care and how to best address them

  • The HCP’s role in education of patients and information dissemination
  • Combatting myths and prejudices

Summary, conclusions, and best practice recap

Learning Objectives

By the end of the session the participant will be able to:

  • Determine the impact of influenza infection.
  • Describe influenza vaccination recommendations and apply them to patient cases.
  • Describe treatment recommendations and apply them to patient cases.
  • Describe present challenges to the prevention and treatment of influenza and develop strategies to combat them.


This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through ScientiaCME. ScientiaCME is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation: ScientiaCME designates this educational activity for a maximum of  1.00 AMA PRA Category 1 Credit(s)™ toward the AMA Physician's Recognition Award. Physicians should only claim credit commensurate with the extent of their participation in the activity.

PhysiciansFor maintenance of certification (MOC) credit, you must enter your board certification ID # and birth date correctly.  It is the learner's responsibility to provide this information completely and accurately at the completion of the activity. Without providing it, the learner will NOT receive MOC credit for this activity. 


ABIM MOC Recognition Statement: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.


ScientiaCME is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmaceutical education. This program is approved for 1.00 hours (0.10 CEUs) of continuing education.  Proof of participation will be posted to your NABP CPE profile within 4 to 6 weeks to participants who have successfully completed the post-test.   Participants must participate in the entire presentation and complete the course evaluation to receive continuing pharmacy education credit.  ACPE # 0574-0000-19-027-H01-P.  ACPE Accreditation effective 7/25/19 and expires 7/25/21. This is a Knowledge (K)-type activity. 

PharmacistsYou must enter your NABP # and birth date correctly so that proof of participation can be posted to your NABP CPE profile. It is the learner's responsibility to provide this information completely and accurately at the completion of the activity. Without providing it, the learner will NOT receive CPE credit for this activity.

Nurse Practitioners (NPs): The American Academy of Nurse Practitioners accepts AMA PRA Category 1 Credit(s)™ from organizations accredited by the ACCME.  ScientiaCME will provide NPs who successfully complete each activity with a certificate of participation indicating that the activity was designated for AMA PRA Category 1 Credit(s)™.

Physician Assistants: The American Academy of Physician Assistants accepts AMA PRA Category 1 Credit(s)™ from organizations accredited by the ACCME.

Faculty Disclosure and Resolution of COI

As a provider of continuing medical education, it is the policy of ScientiaCME to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, faculty and educational planners must disclose any significant relationships with commercial interests whose products or devices may be mentioned in faculty presentations, and any relationships with the commercial supporter of the activity. The intent of this disclosure is to provide the intended audience with information on which they can make their own judgments. Additionally, in the event a conflict of interest (COI) does exist, it is the policy of ScientiaCME to ensure that the COI is resolved in order to ensure the integrity of the CME activity. For this CME activity, any COI has been resolved thru content review ScientiaCME.

Faculty Disclosure:  Diane Birnbaumer, MD, has no relevant conflicts of interest to disclose.

Disclosures of Educational Planners: Charles Turck, PharmD, BCPS, BCCCP, CEO of ScientiaCME, has no relevant conflicts of interest to disclose.

Commercial Support Disclosure: This program is supported by an educational grant from Sanofi Pasteur


  • Read the learning objectives above
  • Take the Pre-Test (optional). Completion of the pre-test will help us evaluate the knowedge gained by participating in this CME activity.
  • View the online activity. You may view this is in more than one session, and may pause or repeat any portion of the presentation if you need to.
  • Take the post-test
  • Complete the activity evaluation and CME registration. A CE certificate will be emailed to you immediately.

Cultural and Linguistic Competence

System Requirements

Windows 7 or above
Internet Explorer 8
*Adobe Acrobat Reader
Mac OS 10.2.8
Safari or Chrome or Firefox
*Adobe Acrobat Reader
Internet Explorer is not supported on the Macintosh

*Required to view Printable PDF Version

Perform Pre-Test (optional)

Please take a few minutes to participate in the optional pre-test. It will help us measure the knowledge gained by participating in this activity.

Additional Courses That Are Related To This Activity

Novel antimicrobials and infectious disease practice: Research updates from ID Week 2019

Updates in vaccine-preventable diseases: Meningococcal meningitis

The problem with vaccines: Public hesitancy and refusal

Coronavirus disease 2019 (COVID-19) preparedness, facts, and management